Skip to content
DataLookout
Menu

NIBANCT04100486

Non-Invasive Bioelectronic Analytics

StatusEnrolling by Invitation
PhaseNot specified
Primary completion (estimated)

At risk: Primary completion moved at least 11 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 10 versions: 10 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Jul 2026 to Jul 2027 Show 5 more changesShow less
    • Eligibility criteria expanded, about 18 words
    • Study completion pushed from Jul 2027 to Jul 2028
    • Secondary endpoints: details revised at 1 of 7 entries
    • Study description revised
    • Publications: details revised at 43 of 43 entries
  2. Notable Primary completion date: Jun 2025 to Jul 2026
    • Study completion date: Sep 2025 to Jul 2027
    v9
  3. Minor Primary completion date: Feb 2025 to Jun 2025
    • Study completion date: May 2025 to Sep 2025
    v8
  4. Notable Primary completion date: Feb 2024 to Feb 2025
    • Study completion date: May 2024 to May 2025
    v7
  5. Notable Primary completion date: Feb 2023 to Feb 2024
    • Study completion date: May 2023 to May 2024
    v6
Show 4 earlier versionsHide 4 earlier versions
  1. Notable Primary completion date: Feb 2022 to Feb 2023
    • Study completion date: May 2022 to May 2023
    v5
  2. Notable Primary completion date: Feb 2021 to Feb 2022
    • Study completion date: May 2021 to May 2022
    v4
  3. Notable Primary completion date: May 2020 to Feb 2021
    • Trial status: Recruiting to Enrolling by Invitation
    • Study completion date: Sep 2020 to May 2021
    • Site details revised
    v3
  4. Minor Primary completion date: Feb 2020 to May 2020v2
  1. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Changes in Heart Rate (Electrocardiography) related to Autonomic Nervous System Perturbations
Timeframe: 4 2-hour sessions over 2 weeks
Changes in Brain Activity (Electroencephalography) related to Autonomic Nervous System Perturbations
Timeframe: 4 2-hour sessions over 2 weeks
Changes in Respiratory Rate related to Autonomic Nervous System Perturbations
Timeframe: 4 2-hour sessions over 2 weeks
Changes in Sweat Gland Activity (Galvanic Skin Response) related to Autonomic Nervous System Perturbations
Timeframe: 4 2-hour sessions over 2 weeks
Changes in Blood Pressure related to Autonomic Nervous System Perturbations
Timeframe: 4 2-hour sessions over 2 weeks
Changes in Skin Temperature related to Autonomic Nervous System Perturbations
Timeframe: 4 2-hour sessions over 2 weeks
Changes in Pupil Size related to Autonomic Nervous System Perturbations
Timeframe: 4 2-hour sessions over 2 weeks

Secondary (7)

Changes in Heart Rate (Electrocardiography) due to taVNS
Changes in Brain Activity (Electroencephalography) due to taVNS
Changes in Respiratory Rate due to taVNS
Changes in Sweat Gland Activity (Galvanic Skin Response) due to taVNS
Changes in Blood Pressure due to taVNS
Show 2 moreShow less
Changes in Skin Temperature due to taVNS
Changes in Pupil Size due to taVNS

Arms and interventions

Healthy, Able-Bodied Individuals

This study will only enroll healthy, able-bodied individuals.

Other: Standing-Squatting-Standing Test, Deep Breathing Test, Cold Pressor Test, Cold Face Test, Valsalva Maneuver

Devices: Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)

Sites

1 site in 1 country

  • The Feinstein Institutes for Medical ResearchManhasset, New York, United States